title: Older antibiotic gains new respect as potent treatment for tuberculosis. Rifapentine is already approved for use with humans.
authors.forename: Eric
authors.initials: E
authors.lastname: Nuermberger
mesh_terms: D000818:Animals; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D004195:Disease Models, Animal; D017277:Drug Approval; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006801:Humans; D051379:Mice; D012293:Rifampin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000904:Antibiotics, Antitubercular; D012293:Rifampin; C018421:rifapentine